$32.53
2.829.49%
At close: -
$32.53
0.000.00%
After Hours: 4:07 PM EDT
Comments
Loading...
Zai Lab Analyst Ratings and Price Targets | NASDAQ:ZLAB | Benzinga
Zai Lab Ltd has a consensus price target of $60.56 based on the ratings of 9 analysts. The high is $95 issued by SVB Leerink on May 11, 2022. The low is $36.1 issued by B of A Securities on March 3, 2025. The 3 most-recent analyst ratings were released by JP Morgan, Scotiabank, and B of A Securities on March 13, 2025, March 7, 2025, and March 3, 2025, respectively. With an average price target of $47.37 between JP Morgan, Scotiabank, and B of A Securities, there's an implied 45.61% upside for Zai Lab Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Scotiabank
B of A Securities
Citigroup
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Zai Lab
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/27/2025 | Buy Now | — | Cantor Fitzgerald | Li Watsek40% | — | Reiterates | Overweight → Overweight | Get Alert |
| 03/13/2025 | Buy Now | 56.78% | JP Morgan | Anupam Rama57% | $44 → $51 | Maintains | Overweight | Get Alert |
| 03/07/2025 | Buy Now | 69.07% | Scotiabank | Louise Chen53% | → $55 | Initiates | → Sector Outperform | Get Alert |
| 03/03/2025 | Buy Now | 10.97% | B of A Securities | David Lim46% | $29 → $36.1 | Downgrade | Buy → Neutral | Get Alert |
| 10/25/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen53% | — | Reiterates | → Overweight | Get Alert |
| 10/21/2024 | Buy Now | 35.26% | JP Morgan | Anupam Rama57% | $38 → $44 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen53% | — | Reiterates | → Overweight | Get Alert |
| 07/12/2024 | Buy Now | 16.82% | JP Morgan | Anupam Rama57% | $43 → $38 | Maintains | Overweight | Get Alert |
| 07/01/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen53% | — | Reiterates | → Overweight | Get Alert |
| 06/25/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen53% | — | Reiterates | → Overweight | Get Alert |
| 02/29/2024 | Buy Now | 102.89% | Citigroup | Yigal Nochomovitz55% | $123 → $66 | Maintains | Buy | Get Alert |
| 12/14/2023 | Buy Now | 46.02% | Morgan Stanley | Jack Lin9% | → $47.5 | Initiates | → Overweight | Get Alert |
| 11/30/2023 | Buy Now | 102.89% | JP Morgan | Anupam Rama57% | $64 → $66 | Maintains | Overweight | Get Alert |
| 10/26/2023 | Buy Now | 293.48% | Citigroup | Yigal Nochomovitz55% | $130 → $128 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | 125.45% | Goldman Sachs | Ziyi Chen69% | $82.47 → $73.34 | Maintains | Buy | Get Alert |
| 10/17/2023 | Buy Now | 96.74% | JP Morgan | Anupam Rama57% | $67 → $64 | Maintains | Overweight | Get Alert |
| 10/09/2023 | Buy Now | 115.19% | Cantor Fitzgerald | Louise Chen53% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 09/18/2023 | Buy Now | 115.19% | Cantor Fitzgerald | Louise Chen53% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 08/10/2023 | Buy Now | 115.19% | Cantor Fitzgerald | Louise Chen53% | → $70 | Initiates | → Overweight | Get Alert |
| 06/12/2023 | Buy Now | 92.13% | B of A Securities | David Lim46% | $75 → $62.5 | Maintains | Buy | Get Alert |
| 05/11/2023 | Buy Now | 299.63% | Citigroup | Yigal Nochomovitz55% | $138 → $130 | Maintains | Buy | Get Alert |
| 03/16/2023 | Buy Now | 115.19% | JP Morgan | Anupam Rama57% | $79 → $70 | Maintains | Overweight | Get Alert |
| 11/18/2022 | Buy Now | 142.85% | JP Morgan | Anupam Rama57% | $96 → $79 | Maintains | Overweight | Get Alert |
| 11/11/2022 | Buy Now | 290.41% | Citigroup | Yigal Nochomovitz55% | $199 → $127 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 511.74% | Citigroup | Yigal Nochomovitz55% | $193 → $199 | Maintains | Buy | Get Alert |
| 05/12/2022 | Buy Now | 493.3% | Citigroup | Yigal Nochomovitz55% | $198 → $193 | Maintains | Buy | Get Alert |
| 05/11/2022 | Buy Now | 192.04% | SVB Leerink | Jonathan Chang39% | $101 → $95 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Zai Lab (ZLAB) stock?
The latest price target for Zai Lab (NASDAQ:ZLAB) was reported by Cantor Fitzgerald on March 27, 2025. The analyst firm set a price target for $0.00 expecting ZLAB to fall to within 12 months (a possible -100.00% downside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zai Lab (ZLAB)?
The latest analyst rating for Zai Lab (NASDAQ:ZLAB) was provided by Cantor Fitzgerald, and Zai Lab reiterated their overweight rating.
When was the last upgrade for Zai Lab (ZLAB)?
There is no last upgrade for Zai Lab
When was the last downgrade for Zai Lab (ZLAB)?
The last downgrade for Zai Lab Ltd happened on March 3, 2025 when B of A Securities changed their price target from $29 to $36.1 for Zai Lab Ltd.
When is the next analyst rating going to be posted or updated for Zai Lab (ZLAB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zai Lab, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zai Lab was filed on March 27, 2025 so you should expect the next rating to be made available sometime around March 27, 2026.
Is the Analyst Rating Zai Lab (ZLAB) correct?
While ratings are subjective and will change, the latest Zai Lab (ZLAB) rating was a reiterated with a price target of $0.00 to $0.00. The current price Zai Lab (ZLAB) is trading at is $32.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
